(Q34776414)

4 August 2017

title

Lopinavir/Ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapy (English)

1 reference

4 August 2017

1 reference

1 reference

1 reference

1 reference

1 reference

Ighovwerha Ofotokun

1

1 reference

4 August 2017

Susan K Chuck

2

1 reference

4 August 2017

Jose N Binongo

3

1 reference

4 August 2017

Mauricio Palau

4

1 reference

4 August 2017

Jeffrey L Lennox

5

1 reference

4 August 2017

Edward P Acosta

6

1 reference

4 August 2017

publication date

5 July 2007

1 reference

The Journal of Clinical Pharmacology

4 August 2017

published in

1 reference

4 August 2017

volume

47

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

970-977

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073482

4 August 2017

1 reference

Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073482

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073482

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073482

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073482

Gender differences in pharmacokinetics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073482

Gender differences in human pharmacokinetics and pharmacodynamics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3073482

Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study

7 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302564

Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302564

Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302564

Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302564

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302564

Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007302564

A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17615254

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17615254

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17615254

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/0091270007302564

1 reference

4 August 2017

1 reference

4 August 2017

1 reference